News Releases

Fred Hutch to serve as national coordinating center for new Asian American, Native Hawaiian and Pacific Islander health studies

Fred Hutch to serve as national coordinating center for new Asian American, Native Hawaiian and Pacific Islander health studies

A $38.7 million federal grant will launch the program focusing on Asian American, Native Hawaiian and Pacific Islander health
News ReleasesSeptember 12, 2023
Fred Hutchinson Cancer Center clinicians named in Seattle Met Magazine’s 2023 Top Doctors list

Fred Hutchinson Cancer Center clinicians named in Seattle Met Magazine’s 2023 Top Doctors list

More than 90 physicians, physician assistants and nurse practitioners recognized
News ReleasesAugust 24, 2023
Policy to expand Medicaid coverage linked to higher participation in cancer clinical trials among people insured by Medicaid

Policy to expand Medicaid coverage linked to higher participation in cancer clinical trials among people insured by Medicaid

Study showed that the Affordable Care Act Medicaid expansion resulted in improvements in access to clinical trials for cancer patients with Medicaid insurance
News ReleasesAugust 17, 2023
Fred Hutch invites community to join Obliteride fundraising event on Saturday, Aug. 12

Fred Hutch invites community to join Obliteride fundraising event on Saturday, Aug. 12

Bike ride and 5K walk/run empowers participants to fundraise and help cure cancer faster.
News ReleasesJuly 13, 2023
Fred Hutch announces new member, leadership on board of directors

Fred Hutch announces new member, leadership on board of directors

Current board members Leigh Morgan elected as chair and Sean Boyle takes on vice chair, Pete Shimer to join board
News ReleasesJune 22, 2023
Researchers identify strong T-cell response in first-in-human nanoparticle HIV vaccine

Researchers identify strong T-cell response in first-in-human nanoparticle HIV vaccine

Study result moves scientists closer to developing elusive HIV vaccine
News ReleasesMay 24, 2023
National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant

National study recommends starting SARS-CoV-2 mRNA vaccination three months after bone marrow transplant

Study involving 22 U.S. cancer centers and research institutions is one of the largest analyses of vaccination for any pathogen within the first year after bone marrow transplant
News ReleasesMay 16, 2023
Fred Hutch study highlights racial disparities in ovarian cancer risk for women

Fred Hutch study highlights racial disparities in ovarian cancer risk for women

Researchers examined risks for Black and white women with endometriosis and fibroids to understand how common medical interventions for those conditions modified the outcomes
News ReleasesMay 04, 2023
Fred Hutchinson Cancer Center opens new clinic building on South Lake Union Campus

Fred Hutchinson Cancer Center opens new clinic building on South Lake Union Campus

New building is designed to serve patients and their families, including innovative improvements in the way cancer care is delivered
News ReleasesMarch 22, 2023
Fred Hutch announces 2023 Harold M. Weintraub Graduate Student Award recipients

Fred Hutch announces 2023 Harold M. Weintraub Graduate Student Award recipients

Twelve graduate students from around the U.S. selected for prestigious award in biological sciences
News ReleasesMarch 01, 2023
Fred Hutch blood and marrow transplant program recognized nationally for patient survival outcomes

Fred Hutch blood and marrow transplant program recognized nationally for patient survival outcomes

Industry data report shows Fred Hutch among 6.3% of U.S. transplant centers to exceed outcomes expectations
News ReleasesFebruary 06, 2023